BioStock article about Scandion Oncology

BioStock has published an article about Scandion Oncology. The focus is on the upcoming clinical Phase II trials that will enroll metastatic colorectal cancer patients that unfortunately no loger benefit from the standard chemotherapy treatment.

The article can be read here: https://www.biostock.se/2019/11/scandion-oncology-ready-for-phase-ii-with-sco-101/

 

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union